Abbott logo
  • Brands
  • Offerings
  • Solutions
  • Knowledge Center



PROFESSIONAL PROFILE


Q&A

HOW HAS YOUR PROFESSIONAL JOURNEY LED TO YOUR CURRENT ROLE WITHIN ABBOTT?

OMER KIRAN: My scientific background – including my undergraduate degree in physics and my Lean and Six Sigma Green Belt certification – have empowered my work in Technical Solutions Design. Through my understanding of physics, I am able to combine an understanding of laboratory processes with solid analytical thinking. This enables me to build powerful models that simulate how a lab can elevate performance by implementing various operational improvements.

ON AVERAGE, HOW MANY LABORATORY WORKFLOWS DO YOU OBSERVE ON AN ANNUAL BASIS AND HOW DOES THIS EXPOSURE SHAPE YOUR APPROACH TO FUTURE ENGAGEMENTS?

OMER KIRAN: Our laboratory partners recognize that even though their challenges may be specific to their market – for example, an accreditation requirement or a need for traceability – the solution requires the kind of diverse and nuanced perspective that can only be gained through intimate contact with 25-30 labs each year. By sharing insights and best practices that we have gained through this vast experience, we are able to provide personalized recommendations that support continuous improvement initiatives.

WHAT MARKET DYNAMICS DO YOU SEE AS BEING THE MOST IMPACTFUL FOR THE LABORATORY – TODAY AND TOMORROW?

OMER KIRAN: When I think about future dynamics that laboratories should be preparing for, the most important ones that come to mind are consolidation, cost pressures, staffing shortages, and better patient engagement – the way the laboratory reaches and interacts with the patient. As more and more people take a proactive role in their health – a trend that accelerated during the pandemic – we are seeing a growing need for labs to be able to work directly with the public.  

WHAT SHOULD LABORATORIES BE THINKING ABOUT AND DOING TO BE BETTER PREPARED FOR THESE DYNAMICS TODAY – AND IN YEARS AHEAD?

OMER KIRAN: As laboratories and health systems develop their strategic plans, it’s important that they identify SMART (Specific, Measurable, Achievable, Realistic, and Timely) goals and KPIs that address the market dynamics that are most relevant to their businesses, and continuously track their performance. They need to build continuous improvement and performance measurement into their operating cultures.

SMART goals, by definition, are specific to each laboratory and health system. This isn’t about measuring turnaround time (TAT) because all labs are concerned with TAT. It’s about setting goals that measurably impact operational performance and integrated care within your lab and your health system. It’s about measuring things that matter. Finding the right KPI set and measuring them is not an easy task. As an example, the lab can optimize workflows, use the highest level of automation, minimize manual intervention, and measure their production capacity and production speed. However, if a certain percentage of samples they receive are being transported incorrectly, they can spend a disproportionate amount of resources and time to solve that issue based on sample integrity. So, it is all about identifying and measuring the right KPIs specific to a lab’s particular needs and going beyond the general KPI sets when needed.

This is an area where having a business intelligence solution in place can facilitate success. With all the daily challenges of running a lab, performance measurement needs to be as simple and systematic as possible. A dashboard that is configured to a lab’s specific goals can be extremely helpful.

Finally, it’s also important to ensure that you’re measuring the right things for the right reasons and that you’re leveraging opportunities for meaningful improvement. As is often said, what can be measured can be improved. What’s also true is that data by itself is interesting at best. It’s what you do with the data that impacts performance and future viability.

SMART GOALS, BY DEFINITION, ARE SPECIFIC TO EACH LABORATORY AND HEALTH SYSTEM. THIS ISN’T ABOUT MEASURING TURNAROUND TIME (TAT) BECAUSE ALL LABS ARE CONCERNED WITH TAT. IT’S ABOUT SETTING GOALS THAT MEASURABLY IMPACT OPERATIONAL PERFORMANCE AND INTEGRATED CARE WITHIN YOUR LAB AND YOUR HEALTH SYSTEM. IT’S ABOUT MEASURING THINGS THAT MATTER.

SIGN UP FOR OUR NEWSLETTER

Sign up to receive the next edition of Healthcare Catalyst where we bring you the latest information, insights, ideas and innovative solutions to improve healthcare through laboratory medicine.

Already an Abbott subscriber? You'll receive new issues of Healthcare Catalyst automatically, no need to sign up.

LATEST ARTICLES

  • SEEING THE BIG PICTURE

    Health systems and laboratories around the world are facing consolidation and cost pressures. In this interview you’ll find insights on how to address these market dynamics through a holistic approach to continuous improvement. 

    Read More
  • THINKING IT THROUGH

    The COVID-19 pandemic has made it clearer than ever that future proofing your lab means being positioned to adapt to ever-changing market conditions. In this interview, you’ll find useful insights on building agility and flexibility into laboratory infrastructure and operating culture.

    Read More
  • FUTURE PROOFING YOUR LAB

    Laboratorio Clínico Toledo (Lab Toledo) is the largest laboratory in the Caribbean. Take a look inside Lab Toledo's 'future proofing' initiative and discover how the laboratory maintains market leadership and pivoted to meet Puerto Rico's need for COVID-19 testing.

    Read More
  • NEVER STOP LEARNING

    This article presents a unique and nuanced perspective on some of the key dynamics facing clinical laboratories, along with thoughts on how continuous learning and collaboration inform effective strategic planning.

    Read More

© 2022 Abbott, Abbott Park, Illinois, U.S.A.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the products or services of the company.

All Alinity hq, CELL-DYN Ruby, CELL-DYN Sapphire and CELL-DYN Emerald 22 AL are Class I laser products. ACCELERATOR a3600 is a Class II laser product.

The Alinity, ACCELERATOR and CELL-DYN systems are intended for performing in vitro diagnostic assays on samples of human origin (blood, urine). Read the instructions in the system manuals and labeling and/or reagent instructions carefully.

ADD-137615-GBL-EN